Healthcare IT News January 9, 2018
Beth Jones Sanborn

Biotechnology was by far the most invested-in group, with $13.8 billion in investments, and Oncology specialty is the biggest draw, AngelMD report shows.

Investment and networking platform AngelMD’s new report shows healthcare technology investment surged ahead in 2017, with California leading the charge and the biotechnology group more than doubling the amount of investment reported.

AngelMD looked at more than 2,500 Securities and Exchange Commission filings to get a clearer picture of where private healthcare investors were spending their money in 2017. Privately held companies that raised funds must file with the SEC to declare exempt offering of securities — making the filings a good barometer for where investments are being made.

[Also: Microsoft vs. Google: Hot start to 2018...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Market Research, Precision Medicine
The Great Tech Wake-Up Call: VCs Discover Billions Wasted On Inefficient Engineering Teams
AI Translates Nature into New Medicines | StartUp Health Insights: Week of Nov 26, 2024
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Infinitus Systems Raises $51.5 Million Series C Funding on the Strength of AI Guardrails
Synapticure Secures $25M To Scale Virtual Care for Neurodegenerative Diseases

Share This Article